股票行情快报：迈得医疗（688310）10月22日主力资金净买入399.25万元

Core Viewpoint - The stock of Maide Medical (688310) has shown a decline in price and mixed capital flow, indicating potential challenges in market performance and investor sentiment [1][2]. Financial Performance - As of October 22, 2025, Maide Medical's stock closed at 20.88 yuan, down 0.67% with a trading volume of 27,500 hands and a transaction amount of 57.62 million yuan [1]. - The company's main revenue for the first half of 2025 was 141 million yuan, a year-on-year decrease of 14.75%, while the net profit attributable to shareholders was 6.05 million yuan, down 38.81% year-on-year [3]. - The second quarter of 2025 showed a single-quarter main revenue of 101 million yuan, an increase of 10.58% year-on-year, and a net profit of 16.84 million yuan, up 2759.64% year-on-year [3]. Capital Flow Analysis - On October 22, 2025, the net inflow of main funds was 3.99 million yuan, accounting for 6.93% of the total transaction amount, while retail investors saw a net inflow of 2.47 million yuan, representing 4.29% of the total [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with significant net outflows from speculative funds on several days [2]. Industry Comparison - Maide Medical's total market value is 3.471 billion yuan, significantly lower than the industry average of 7.648 billion yuan, ranking 186 out of 268 in the specialized equipment industry [3]. - The company's price-to-earnings ratio (P/E) stands at 287.07, compared to the industry average of 48.9, indicating a high valuation relative to earnings [3]. - The gross profit margin of Maide Medical is 38.93%, which is above the industry average of 27.76%, but the net profit margin is negative at -1.29%, compared to a positive 0.54% industry average [3].